Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Hemispherx Biopharma Inc (NYSE MKT LLC:HEB)

0.185
Delayed Data
As of Jul 30
 +0.002 / +1.09%
Today’s Change
0.17
Today|||52-Week Range
0.40
-26.00%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 2
2014
Quarter 3
2014
Quarter 4
2014
Quarter 1
2015
Revenue and IncomeNet Revenues36.0K45.0K40.0K36.0K
 
 
 
 
 
Cost of Goods Sold18.0K153.0K100.0K121.0K
 
 
 
 
 
Depreciation And Amortization276.0K306.0K228.0K251.0K
 
 
 
 
 
 
Operating ExpensesGross Income-258.0K-414.0K-288.0K-336.0K
 
 
 
 
 
General Expenses4.8M3.9M4.3M4.6M
 
 
 
 
 
Research And Development2.3M1.9M2.4M2.7M
 
 
 
 
 
Total Operating Expenses5.1M4.4M4.6M5.0M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-5.1M-4.3M-4.6M-4.9M
 
 
 
 
 
Extraordinary Credit1.0K--13.0K0.00
 
 
 
Extraordinary Charge0.00---145.0K--
 
 
Interest Expense On Debt3.0K3.0K2.0K2.0K
 
 
 
 
 
Other Expenses0.000.000.001.4M
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-5.0M-4.2M-4.5M-3.4M
 
 
 
 
 
Net Income-5.0M-4.2M-4.5M-3.4M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS185.7M190.7M204.0M213.6M
 
 
 
 
 
Shares To Calculate EPS Diluted185.7M190.7M204.0M213.6M
 
 
 
 
 
 
Earnings Per ShareEPS-$0.03-$0.02-$0.02-$0.02
 
 
 
 
 
EPS Diluted-$0.03-$0.02-$0.02-$0.02